We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Barriers to Adherence to Asthma Controller Meds in Low Income Urban Minority Adolescents (ADEPT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00967720
First Posted: August 28, 2009
Last Update Posted: August 28, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rush University Medical Center
  Purpose
Poor adherence to appropriate asthma medications is an important risk factor contributing to high asthma morbidity and mortality in urban African American adolescents. As part of the ADEPT (Adolescent Disease Empowerment and Persistency Technology) for Asthma Pilot 2 study, a focus group was developed specifically to explore existing barriers to adherence among inner city African American adolescent asthmatics.

Condition
Asthma

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Qualitative Analysis of the Barriers to Adherence With Asthma Controller Medication Among Inner City African American Adolescents as Identified Through Focus Group Data

Resource links provided by NLM:


Further study details as provided by Rush University Medical Center:

Primary Outcome Measures:
  • Focus groups explored whether a new communication medium improved adherence to asthma controller medications and to examine existing barriers to adherence among four urban African American adolescents with uncontrolled moderate persistent asthma

Enrollment: 4
Study Start Date: March 2008
Study Completion Date: August 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
Barriers, Adherence, Asthma

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
four low income urban adolescents with uncontrolled moderate persistent asthma
Criteria

Inclusion Criteria:

  • 12-18 years of age
  • self identify as African American
  • have persistent asthma
  • read at a minimum fourth grade reading level
  • be on a prescribed daily inhaled corticosteroid medication for asthma

Exclusion Criteria:

  • candidate refusal or presence of other co-morbidities
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00967720


Sponsors and Collaborators
Rush University Medical Center
Investigators
Principal Investigator: Giselle S Mosnaim, MD Rush University Medical Center
  More Information

Responsible Party: Giselle Mosnaim, MD, Rush University Medical Center
ClinicalTrials.gov Identifier: NCT00967720     History of Changes
Other Study ID Numbers: 08021601
First Submitted: August 26, 2009
First Posted: August 28, 2009
Last Update Posted: August 28, 2009
Last Verified: August 2009

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases